您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8473 处方药 8099 非处方药 268 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 美国
所属类别: 抗癌药物->恶性胸腔积液
处方药:处方药
包装规格: 5盎司/瓶
计价单位:
  点击放大  
生产厂家中文参考译名:
Emerson Healthcare
生产厂家英文名:
Emerson Healthcare
该药品相关信息网址1:
www.bryancorp.com/intrapleural-aerosol.cfm
该药品相关信息网址2:
www.drugs.com/pro/sclerosol.html
原产地英文商品名:
CALDESENE POWDER(SCLEROSOL GENERIC) 5oz/bottle
原产地英文药品名:
TALC
中文参考商品译名:
CALDESENE粉剂(司兰索仿制药) 5盎司/瓶
中文参考药品译名:
滑石粉
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
malignant pleural ef
英文适应病症2:
malignancy
英文适应病症3:
tumor
英文适应病症4:
cancer
临床试验期:
完成
中文适应病症参考翻译1:
恶性肿瘤性胸腔积液
中文适应病症参考翻译2:
恶性肿瘤
中文适应病症参考翻译3:
肿瘤
中文适应病症参考翻译4:
癌症
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20127118420728.PDF)的“原文Priscribing Information”为准
---------------------------------------------------------------
 部分中文Sclerosol处方资料(仅供参考)

Sclerosol Intrapleural Aerosol:治疗恶性胸腔积液; Bryan Corporation生产; 1998年1月批准上市

【通用名称】SCLEROSOL

【剂  型】AEROSOL, METERED; INTRAPLEURAL

【规  格】400MG/SPRAY

【活性成份】TALC

Sclerosol Intrapleural Aerosol
Company: Bryan Corporation
Approval Status: Approved January 1998
Treatment for: malignant pleural effusions
Areas: Cancer & Oncology; Respiratory

Adult Dosing & Uses
Dosing Forms & Strengths
intrapleural aerosol
•4g/25g propellant, delivers 400mg/second

sclerosing powder
•5g/100mL bottle

Malignant Pleural Effusion
Indicated as a sclerosing agent to decrease malignant pleural effusion recurrence in symptomatic patients

Administered intrapleurally via chest tube after adequate drainage of the effusion

Sclerosol: 4-8 g (1-2 canisters); deliver by manually pressing actuator button; distal end of the delivery tube should be pointed in several different directions, while short bursts are administered to distribute talc powder equally and extensively on all visceral and parietal pleural surfaces

Sterile Talc Powder: 5 g dissolved in 50-100 mL 0.9% NaCl

General Information
Sclerosol Intrapleural Aerosol has been approved for the prevention of recurrence of malignant pleural effusions in symptomatic patients. Symptoms include chest pain, dyspnea, and coughing. It is to be administered by aerosol during thracoscopy or open thoracotomy.

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(20127118420728.PDF)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2012-7-2
附件:
20127118420728.PDF    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com